Wound treatment system with wound volume estimation
By using pressure monitoring and model data in negative pressure wound treatment systems, accurately estimating the fluid volume at the wound site and monitoring the healing process, the problems of estimation difficulties and fluid overfilling in existing systems are solved, improving the efficiency and accuracy of treatment.
Patent Information
- Application Number
- CN201980094086.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2019-03-27
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2039-03-27
AI Technical Summary
Existing negative pressure wound treatment systems have difficulty accurately estimating the volume of fluid delivered at the wound site and monitoring wound healing progress, and are difficult to prevent overfilling of fluids and interpret changes in the removal of fluid tanks.
Pressure is monitored using a pump and controller, combined with model pressure attenuation data, fluid volume is determined, and under automatic operation of the controller, preventing fluid overfilling and monitoring of healing progress.
Accurate estimation of the fluid volume at the wound site and monitoring of the healing process are achieved, avoiding fluid overfilling, simplifying the treatment process, and reducing time and step requirements.
Smart Images

Figure CN113613692B_ABST
Abstract
Description
Background Art
[0001] The present disclosure relates generally to a wound treatment system, and more particularly to a wound treatment system configured to estimate a volume relative to a wound site.
[0002] Negative pressure wound therapy (NPWT) is a type of wound therapy that involves applying negative pressure to a treatment site to promote wound healing. Recent advances in wound healing using NPWT involve applying topical fluids to the wound to work in combination with NPWT. However, it may be difficult to determine the appropriate volume of instillation fluid delivered to the wound. In addition, it may be difficult to accurately monitor and track the healing progress of the wound over time. Therefore, it is advantageous to provide a system and method that allows accurate and reliable estimation of the available space at the wound site into which the instillation fluid can be delivered and estimates the healing progress of the wound site over time. Advantageously, such systems and methods will additionally allow such volume determinations automatically performed by a controller to be performed at any stage during NPWT treatment, will not require any additional time and / or steps to perform compared to typical NPWT treatments, will allow overfill detection and / or prevention during the fluid instillation cycle, and / or can account for changes in the type or size of removal fluid tanks used during NPWT treatment. Summary of the invention
[0003] In one embodiment of the present disclosure, a method includes operably connecting a first end of a fluid tube to a fluid tank and a pump of a treatment device, and operably connecting a second end of the fluid tube to a wound dressing applied to a wound site. Operating the pump until a predetermined first negative pressure is detected. Instilling a first amount of fluid into the wound site until a first predetermined target pressure is detected. Monitoring pressure during instillation of the first amount of fluid into the wound site. Determining a volume of the first amount of fluid instilled into the wound site using a pressure measurement obtained from the pressure monitored during instillation of the first amount of fluid into the wound site.
[0004] According to some embodiments, determining the volume of the first amount of fluid instilled into the wound site includes comparing the obtained pressure measurement results to model pressure decay data. According to some embodiments, the model pressure decay data represents the pressure decay within the container when a predetermined amount of fluid is instilled into a container with a known volume. According to some embodiments, the model pressure decay data includes pressure decay data for a plurality of containers with known volumes.
[0005] According to some embodiments, the determined volume of the first amount of fluid instilled into the wound site is stored. According to some embodiments, the first predetermined target pressure is about 0 mmHg. According to some embodiments, the pump is operated until a predetermined second negative pressure is detected. According to some embodiments, a second amount of fluid is instilled into the wound site until a second predetermined target pressure is detected. According to some embodiments, the pressure is monitored during the instillation of the second amount of fluid into the wound site.
[0006] According to some embodiments, the volume of the second amount of fluid instilled into the wound site is determined using pressure measurements obtained from pressure monitored during instillation of the second amount of fluid into the wound site.According to some embodiments, the second predetermined target pressure is about 0 mmHg.
[0007] According to some embodiments, a first amount of fluid is instilled into the wound site at a predetermined flow rate. According to some embodiments, a second amount of fluid is instilled into the wound site at a predetermined flow rate. According to some embodiments, the determined volume of the second amount of fluid instilled into the wound site is stored. According to some embodiments, a wound healing rate is determined by comparing the first storage volume to the second storage volume.
[0008] In one embodiment of the present disclosure, a method for preventing overfilling of a wound site with a fluid includes operably connecting a first end of a fluid tube to a fluid tank and a pump of a treatment device, and operably connecting a second end of the fluid tube to a wound dressing applied to the wound site. Operating the pump to achieve a predetermined first negative pressure. Instilling the fluid into the wound site. Monitoring the pressure during instillation of the fluid into the wound site. In response to detecting the first predetermined target pressure, stopping instillation of the fluid into the wound site.
[0009] According to some embodiments, the first predetermined target pressure is 0 mmHg. According to some embodiments, the volume of the wound site is estimated before the fluid is instilled into the wound site. According to some embodiments, model pressure decay data representing the pressure decay within the container when different amounts of fluid are instilled into the container is obtained, the container having a volume equal to the estimated volume of the wound site. According to some embodiments, monitoring the pressure includes obtaining a measurement of the pressure. According to some embodiments, the obtained pressure measurement is compared in real time with the model pressure decay data. According to some embodiments, an alarm is generated if the measured pressure does not correspond to the model pressure decay data.
[0010] According to some embodiments, the volume of the fluid instilled into the wound site is determined. According to some embodiments, the volume of the fluid instilled into the wound site is determined using pressure measurements obtained from pressure monitored during instillation of the fluid into the wound site. According to some embodiments, determining the volume of the fluid instilled into the wound site includes comparing the obtained pressure measurements to model pressure decay data.
[0011] According to some embodiments, the second predetermined pressure is 0 mmHg. According to some embodiments, the estimated volume of the wound site is compared with the determined volume of the fluid instilled into the wound site. According to some embodiments, if the estimated volume of the wound site is substantially different from the determined volume of the fluid instilled into the wound site, an alarm is generated.
[0012] In one implementation of the present disclosure, a wound treatment system includes a pump, a wound dressing configured to be applied to a wound site, a fluid tube fluidically connecting the pump to the wound dressing, and a controller. The controller is configured to monitor pressure during instillation of fluid into the wound site and determine a volume of fluid instilled into the wound site using pressure measurements obtained from the pressure monitored during instillation of fluid into the wound site.
[0013] According to some embodiments, the controller is configured to determine the volume of fluid instilled into the wound by comparing the obtained pressure measurement results with the model pressure decay data. According to some embodiments, the controller is configured to store the determined volume of the fluid instilled into the wound site. According to some embodiments, the controller is configured to determine the volume of the fluid instilled into the wound site at each instillation event of one or more instillation events occurring during treatment of the wound site. According to some embodiments, the controller is configured to store each of the determined volumes. According to some embodiments, the controller is configured to monitor the healing of the wound site based on the stored determined volumes.
[0014] According to some embodiments, the wound treatment system further comprises a source of instillation fluid. The controller is further configured to operate the pump to instill the fluid into the wound site. According to some embodiments, the controller is configured to stop instilling the fluid into the wound site when a first predetermined pressure is detected. According to some embodiments, the controller is configured to stop operation of the pump when a pressure of substantially 0 mmHg is detected. According to some embodiments, the controller is further configured to operate the pump to exhaust air from the wound site.
[0015] According to some embodiments, the controller is further configured to operate the pump to exhaust air from the wound site to achieve a predetermined negative pressure. When the pressure is detected to be equal to the predetermined negative pressure, the controller is configured to operate the pump to drip the fluid into the wound site. The controller is configured to stop dripping the fluid into the wound site when the measured pressure is detected to be equal to the predetermined target pressure.
[0016] In one embodiment of the present disclosure, a wound treatment system includes a pump, a wound dressing configured to be applied to a wound site, a fluid tube fluidically connecting the pump to the wound dressing, an instillation fluid source, and a controller. The controller is configured to operate the pump to instill the instillation fluid into the wound site and monitor the pressure during the instillation of the fluid into the wound site. The controller is configured to stop the operation of the pump in response to detecting a first predetermined pressure.
[0017] According to some embodiments, the predetermined pressure is 0 mmHg. According to some embodiments, the controller is configured to obtain the estimated volume of the wound site before operating the pump to instill the fluid into the wound site. According to some embodiments, the controller is configured to obtain pressure measurements based on the pressure monitored during the operation of the pump to instill the fluid into the wound site. According to some embodiments, the controller is configured to obtain model pressure decay data representing the pressure decay in the container when the fluid is instilled into the container, and the container has a volume equal to the estimated volume of the wound site. According to some embodiments, the controller is further configured to compare the pressure measurements with the model pressure decay data in real time.
[0018] According to some embodiments, if the measured pressure does not correspond to the model pressure decay data, an alarm is generated. According to some embodiments, the estimated volume of the wound site is obtained by the controller by operating a pump to evacuate air from the wound site.
[0019] According to some embodiments, the controller is further configured to operate the pump to exhaust air from the wound site and monitor the pressure when the air is exhausted from the wound site. The controller is further configured to stop the operation of the pump when a predetermined negative pressure is detected. According to some embodiments, the controller is configured to operate the pump to instill the instillation fluid into the wound site after detecting the predetermined negative pressure.
[0020] According to some embodiments, the controller is configured to use pressure measurements obtained from the pressure monitored during instillation of the fluid into the wound site to estimate the volume of the fluid instilled into the wound site. According to some embodiments, the controller is configured to compare the obtained pressure measurements with model pressure decay data to estimate the volume of the fluid instilled into the wound site. According to some embodiments, the model pressure decay data represents the pressure decay within the container during instillation of the fluid into a container with a known volume.
[0021] According to some embodiments, the controller is configured to obtain an estimate of the volume of the wound site. According to some embodiments, the estimated volume of the wound site is compared to the determined volume of the fluid instilled into the wound site. According to some embodiments, an alarm is generated if the estimated volume of the wound site is substantially different from the determined volume of the fluid instilled into the wound site.
[0022] Those skilled in the art will appreciate that the inventive content is only exemplary and is not intended to be limiting in any way. As limited only by the claims, other aspects, inventive features and advantages of the devices and / or processes described herein will become apparent in the specific embodiments described herein and in conjunction with the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 is a block diagram of a negative pressure wound therapy system including a therapy device coupled to a wound dressing via tubing according to an exemplary embodiment.
[0024] Figure 2 is a more detailed illustration of the exemplary embodiment according to Figure 1 Block diagram of a negative pressure wound therapy system.
[0025] Figure 3 is a more detailed illustration of the exemplary embodiment according to Figure 1 Block diagram of the negative pressure circuit, fluid removal tank circuit, and wound site circuit of a negative pressure wound therapy system.
[0026] Figure 4 is a block diagram illustrating a negative pressure wound therapy system according to an exemplary embodiment.
[0027] Figure 5 is a flow chart of a method of using a negative pressure wound therapy system according to an exemplary embodiment.
[0028] Figure 6 is a flow chart of a process for monitoring the healing progress of a wound site over time according to an exemplary embodiment.
[0029] Figure 7 is a flow chart of a method of using a negative pressure wound therapy system according to an exemplary embodiment.
[0030] Figure 8 is a flow chart of a method of using a negative pressure wound therapy system according to an exemplary embodiment. DETAILED DESCRIPTION
[0031] Overview
[0032] Referring generally to the accompanying drawings, a wound treatment system according to various exemplary embodiments is shown. The wound treatment system may include a treatment device and a wound dressing. The treatment device may include an instillation fluid tank, a removable fluid tank, a valve, a pneumatic pump, an instillation pump, and a controller. The wound dressing may be applied to the skin around the wound of the patient. The treatment device may be configured to deliver the instillation fluid to the wound and provide negative pressure wound therapy (NPWT) by maintaining the wound under negative pressure. The components of the wound treatment device, the wound dressing, and the wound site form a negative pressure loop.
[0033] The controller may be configured to operate a pneumatic pump, an infusion pump, and / or other controllable components of the treatment device. According to some embodiments in which NPWT treatment provided using the NPWT system includes instilling an infusion fluid into a wound site, the controller may be configured to estimate the volume of the wound site and / or the volume of the amount of infusion fluid delivered to the wound site based on a comparison of the dynamic pressure response observed when the fluid is instilled into the wound site with the model pressure response data. Because the dynamic pressure response is observed while instilling the fluid into the wound site, the systems and methods described herein are configured to allow the controller to estimate the wound site volume without requiring any additional steps and / or time than would otherwise be required to provide infusion therapy treatment using the NPWT system.
[0034] According to some embodiments, the wound site volume estimate based on the dynamic pressure response observed during fluid instillation can be used for validation and / or can be validated using wound site volume estimates obtained using any other number of methods to provide a NPWT system with a higher confidence wound site volume estimate. For example, in some embodiments, the controller can compare the wound site volume estimated based on the dynamic pressure response observed during fluid instillation with the wound site volume estimated based on a comparison of the dynamic pressure response observed during negative pressure purge within the entire negative pressure circuit and / or a selected portion of the negative pressure circuit.
[0035] In various embodiments, the controller may additionally or alternatively be configured to prevent and / or detect overfilling during instillation of the instillation fluid into the wound site. According to some such embodiments, the controller may use a previously obtained wound site volume estimate (e.g., estimated during pre-instillation of the fluid into the wound site; based on a comparison of the dynamic pressure response observed during the purge of negative pressure from the negative pressure loop; etc.) as a backstop value, and the volume of a certain amount of fluid that has been instilled into the wound site is compared to the backstop value to prevent overfilling the wound site with the instillation fluid. In some embodiments, the previously obtained wound site volume estimate may additionally or alternatively be used to identify a model pressure decay curve that represents the expected dynamic pressure response during instillation of the instillation fluid into the wound site to reach a predetermined target pressure, as measured, for example, at any one or more of the following locations: at the wound site, in a tube that fluidly connects the wound site to the treatment device, in a removed fluid tank, at the treatment device, etc. In such embodiments, the dynamic pressure response at the wound site is monitored in real time and compared to a model pressure decay curve, where deviations in the monitored pressure from the expected pressure based on the model decay curve are used to alert the controller to a possible overfill condition that may need to be addressed.
[0036] In some embodiments, the controller may additionally or alternatively estimate and monitor the volume of the wound site multiple times during wound treatment, wherein the controller determines the progress of the healing of the wound site based on changes in the estimated wound site volume over the course of NPWT treatment. By monitoring the progress of the healing of the wound site, the controller may be configured to alert the user if healing of the wound site is not proceeding as expected or desired. It should be understood that in some embodiments, monitoring changes in the estimated wound site volume over time may additionally advantageously provide the controller with more accurate values that allow the controller to more accurately detect and / or prevent overfilling of the wound site with the instillation fluid. These and other features of the wound treatment system are described in detail below.
[0037] Wound therapy system
[0038] See now Figure 1, a negative pressure wound therapy (NPWT) system 100 is shown according to an exemplary embodiment. The NPWT system 100 is shown to include a treatment device 102 fluidly connected to a wound dressing 112 via tubes 108 and 110. According to various embodiments, the wound dressing 112 can be placed on or within a wound site 114 and adhered or sealed to the patient's skin 116 surrounding the wound site 114 using a drape layer 117. Several examples of wound dressings 112 that can be used in combination with the NPWT system 100 are also described in detail in U.S. Patent 7,651,484, issued on January 26, 2010, U.S. Patent 8,394,081, issued on March 12, 2013, and U.S. Patent Application 14 / 087,418, filed on November 22, 2013. The entire disclosure of each of these patents and patent applications is incorporated herein by reference.
[0039] like Figure 2 , in general, the therapeutic device 102 includes a pneumatic pump 120, an infusion pump 122, a filter 128, and a controller 118. The pneumatic pump 120 may be fluidly coupled to the removal fluid tank 106 (e.g., via a conduit 136), and may be configured to evacuate the tank 106 by pumping air out of the tank 106. In some embodiments, the pneumatic pump 120 is configured to operate in both a forward direction and a reverse direction. For example, the pneumatic pump 120 may operate in a forward direction to pump air out of the tank 106 and reduce the pressure within the tank 106. The pneumatic pump 120 may operate in a reverse direction to pump air into the tank 106 and increase the pressure within the tank 106. The pneumatic pump 120 may be controlled by the controller 118, which will be described in more detail below.
[0040] The treatment device 102 may be configured to provide negative pressure wound therapy by reducing the pressure at the wound site 114. The treatment device 102 may be vacuumed (relative to atmospheric pressure) at the wound site 114 by removing wound exudate, air and other fluids from the wound site 114. The wound exudate may include fluid filtered from the patient's circulatory system to the lesion or inflammation area. For example, the wound exudate may include water and dissolved solutes, such as blood, plasma proteins, white blood cells, platelets and red blood cells. Other fluids 121 removed from the wound site 114 may include the instillation fluid 105 previously delivered to the wound site 114. The instillation fluid 105 may include, for example, a cleaning fluid, a prescription fluid, a drug-carrying fluid, an antibiotic fluid or any other type of fluid that may be delivered to the wound site 114 during wound treatment. The instillation fluid 105 may be maintained in the instillation fluid tank 104 and controllably distributed to the wound site 114 via the tube 108. In some embodiments, the instillation fluid tank 104 can be disassembled from the treatment device 102 to allow the tank 104 to be refilled and replaced as needed.
[0041] The drip pump 122 can be fluidly coupled to the drip fluid tank 104 and the wound dressing 112 via the drip tube 108. The drip pump 122 can be operated to deliver the drip fluid 105 to the wound dressing 112 and the wound site 114 by pumping the drip fluid 105 through the drip tube 108. The drip pump 122 can be controlled by the controller 118, which will be described in more detail below. According to some embodiments, the drip pump 122 can be defined by all or a portion of the pneumatic pump 120.
[0042] The filter 128 may be positioned between the removal fluid tank 106 and the pneumatic pump 120 (e.g., along the conduit 136) such that air pumped from the tank 106 passes through the filter 128. The filter 128 may be configured to prevent liquid or solid particles from entering the conduit 136 and reaching the pneumatic pump 120. The filter 128 may include, for example, a hydrophobic and / or lipophilic bacterial filter such that aqueous liquids and / or oily liquids will bead up on the surface of the filter 128. The pneumatic pump 120 may be configured to provide sufficient airflow through the filter 128 such that a pressure drop across the filter 128 is not significant (e.g., such that the pressure drop will not substantially impede the application of negative pressure from the treatment device 102 to the wound site 114).
[0043] The removal fluid tank 106 can be a component of the treatment device 102 that is configured to collect wound exudate and other fluids 121 removed from the wound site 114. In some embodiments, the removal fluid tank 106 can be detachable from the treatment device 102 to allow the tank 106 to be emptied and replaced as needed. The lower portion of the tank 106 can be filled with wound exudate and other fluids 107 removed from the wound site 114, while the upper portion of the tank 106 can be filled with air. The treatment device 102 can be configured to draw a vacuum within the tank 106 by pumping air out of the tank 106. The reduced pressure within the tank 106 can be transferred to the wound dressing 112 and the wound site 114 via the tube 110.
[0044] like Figure 1 As shown, a tube valve 111 (e.g., spring biased, duckbill structure, check valve, etc.) may be disposed along the tube 110 at a position between the removed fluid tank 106 and the wound site 114 , which is configured to prevent fluid from flowing from the removed fluid tank 106 to the wound site 114 .
[0045] See also Figure 3 1, the removed fluid tank 106, the tube 110, the conduit 136 extending between the pneumatic pump 120 and the removed fluid tank 106, and the wound site 114 are fluidly connected to define a negative pressure circuit 200. As will be discussed in more detail below, the volume of the tube 110 and the conduit 136 define a known volume that can be easily subtracted from or otherwise accounted for in calculations relative to the volume of the wound site 114. Figure 2 As shown, according to various embodiments, a vent hole 132 may be provided through which the vacuum within the negative pressure circuit 200 may be purged.
[0046] If you will refer to Figure 8 Further described, according to some embodiments, it may be desirable to validate the volume estimated using any of the methods described herein relative to volume estimates obtained using other methods and / or from other sources (such as volumes estimated based on measurements obtained during trimming of a negative pressure circuit), such as described in related co-pending U.S. Provisional Application No. 62 / 714,229, filed on August 3, 2018, entitled “WOUND THERAPY SYSTEM WITH WOUND VOLUME ESTIMATION,” the entire disclosure of which is incorporated herein by reference. Thus, as Figure 4 As shown, according to various embodiments, the NPWT system 100 may optionally include one or more features that are configured to enable the NPWT system 100 to be used to estimate volume using any number of other methods in addition to the various methods of estimating volume during fluid instillation described herein.
[0047] For example, Figure 4 As shown, the NPWT system 100 may include features similar to those described in the various systems described in the co-pending U.S. Provisional Application No. 62 / 714,229 with reference to the related patent application. Specifically, according to some embodiments, the reference Figure 1 The embodiment of the pipe valve 111 is described, wherein Figure 4 The tube valve 111' of the embodiment is configured to selectively allow and prevent fluid flow between the removed fluid tank 106 and the wound site 114, thereby allowing the negative pressure circuit 200 to be selectively fluidly divided into the removed fluid tank circuit (i.e., the portion of the negative pressure circuit located upstream of the tube valve 111') and the wound site circuit (i.e., the portion of the negative pressure circuit located downstream of the tube valve 111'). See again Figure 4 According to some embodiments, the NPWT system 100 may also be provided with a graduated leakage system 113 configured to selectively control and measure airflow between the tube 110 and the ambient environment surrounding the treatment device 102. According to various embodiments, the graduated leakage system 113 may be selectively opened to allow airflow into the tube 110 at a known predetermined rate.
[0048] like Figure 2, according to various embodiments, the controller 118 may be configured to operate various components of the treatment device 102. Specifically, as will be described in more detail below, according to various embodiments, the controller 118 may be configured to control various components of the NPWT system 100 to perform one or more volume determination processes, via which, for example, an estimated volume of the wound site 114 may be determined, the healing progress of the wound site may be tracked, etc. According to various embodiments, the controller 118 may be configured such that these processes may be performed with minimal user intervention and / or input.
[0049] According to various embodiments, the NPWT system 100 may include various sensors. For example, in some embodiments, one or more pressure sensors 115 may be located at any one or more of the following locations: embedded in the tube 110, at the wound dressing 112, at the removed fluid tank 106, at the treatment device 102, at the pump 120, etc., so as to allow measurement of pressure at any one or more of the following locations: at the removed fluid tank 106, within the tube 110, and / or at the wound site 114. The pressure measurements recorded by the pressure sensors 115 may be transmitted to the controller 118. According to various embodiments, the controller 118 may use the pressure measurements from the pressure sensors 115 as input to various pressure testing operations and control operations performed by the controller 118.
[0050] In some embodiments, the therapeutic device 102 includes a user interface 126. The user interface 126 may include one or more buttons, dials, slide bars, keys, or other input devices configured to receive input from a user. The user interface 126 may also include one or more display devices (e.g., LEDs, LCD displays, etc.), speakers, tactile feedback devices, or other output devices configured to provide information to the user. The user interface 126 may also display an alarm generated by the controller 118. For example, if the tank 106 is not detected, the controller 118 may generate a "no tank" alarm.
[0051] In some embodiments, the therapeutic device 102 includes a data communication interface 124 (e.g., a USB port, a wireless transceiver, etc.) configured to receive and transmit data. The communication interface 124 may include a wired or wireless communication interface (e.g., a jack, an antenna, a transmitter, a receiver, a transceiver, a line terminal, etc.) for communicating data with an external system or device. In various embodiments, the communication may be direct (e.g., local wired or wireless communication) or via a communication network (e.g., a WAN, the Internet, a cellular network, etc.). For example, the communication interface 124 may include a USB port or an Ethernet card and a port for sending and receiving data via an Ethernet-based communication link or network. In another example, the communication interface 124 may include a Wi-Fi transceiver or a cellular or mobile phone communication transceiver for communicating via a wireless communication network.
[0052] How to use
[0053] See also Figure 5 , a flow chart is shown detailing the steps of a method 500 for using the NPWT system 100 according to an exemplary embodiment. Figure 5 As shown, at step 502, a NPWT system 100 (such as Figure 1 502 ), wherein the drape layer 117 and wound dressing 112 of the NPWT system 100 are positioned at a desired wound site 114 to be treated. According to some embodiments, as part of the initiation of treatment at step 502, and prior to proceeding with the remaining steps of method 500, any number of different methods may be used to confirm that the drape layer 117 and wound dressing 112 have been properly sealed around the wound site 114. For example, according to some embodiments, after operating the pneumatic pump 120 to evacuate air from the wound site 114, the pressure may be monitored (e.g., using the pressure sensor 115) to confirm that there is no unintentional leakage of air from the wound site 114. According to various embodiments, the pressure that may be monitored may be any one or more of the following: the pressure within the tube 110, the pressure within the removed fluid tank 106, the pressure at the treatment device 102, the pressure at the wound site 114, the pressure at the pump 120, etc. It should be understood that in other embodiments, such confirmation of a proper seal between the wound dressing 112 / drape layer 117 and the wound site 114 may alternatively be performed as part of and / or during subsequent steps of the method 500 .
[0054] In addition to confirming that there are no leaks in the assembled NPWT system 100, according to some embodiments, step 502 may also optionally include the step of obtaining model data. The model data represents the change in pressure over time when the instillation fluid is instilled into a wound site of different volumes under various clinically relevant conditions and states (e.g., different instillation rates, wound volumes, dressing / foam properties, dressing leakage rates, starting pressures, predetermined target pressures, etc.). Such model data may be generated using any number of various function approximators, statistical methods, machine learning systems, etc., or a combination thereof. The model data obtained at step 502 may include any number of different pressure decay curves, functions, lookup tables, etc., and may be obtained as pre-existing information input and stored by the controller, and / or may be obtained and processed by the controller 118 during an optional initial training process performed by the controller 118 before using the NPWT system 100 to treat the wound site 114 (e.g., before the method 500 begins or as part of the initial setup of the NPWT system 100 at step 502). A non-limiting example of an embodiment of a training process that can be used by the controller 118 to generate such a relationship is outlined in the related co-pending U.S. Provisional Application No. 62 / 650,132, filed on April 17, 2018, entitled "WOUND THERAPY SYSTEM WITH WOUND VOLUME ESTIMATION," the entire disclosure of which is incorporated herein by reference. It should be understood that in embodiments in which the volume of the wound site 114 is additionally estimated during negative pressure purges within all or part of the negative pressure circuit 200, model data representing changes in pressure over time when ambient air is allowed to flow into all or part of the negative pressure circuit 200 under various clinically relevant conditions and states can be additionally obtained in a substantially similar manner.
[0055] Once setup of the NPWT system 100 at step 502 is completed, the pneumatic pump 120 is operated (manually or using the controller 118) to reach a predetermined negative pressure at step 504. After the predetermined target pressure has been reached, the instillation pump 122 (which may be the same or different from the pneumatic pump 120) is operated at step 506 to instill the instillation fluid 105 into the wound site 114. At step 506, the instillation fluid 105 is instilled into the wound site 114 until the predetermined target pressure is reached. According to various embodiments, the target pressure and / or the predetermined negative pressure may correspond to a pressure as measured at any one or more of the tube 110, the removed fluid tank 106, the treatment device 102, the wound site 114, the pump 120, etc. According to various embodiments, the predetermined target pressure may be between about -15 mmHg and about 15 mmHg, more specifically between about -5 mmHg and 5 mmHg, and even more specifically about 0 mmHg.
[0056] At step 508, the pressure decay monitored at any one or more of the tube 110, the removed fluid canister 106, the treatment device 102, the wound site 114, etc. (such pressure decay may be an increase in pressure over time) during the instillation of the instillation fluid 105 into the wound site 114 at step 506 may be used to estimate the volume of the wound site 114. According to some embodiments, the wound site 114 volume estimation may be based on a comparison of the measured dynamic pressure during the fluid instillation at step 506 with model pressure decay data obtained before or during step 502. Because the wound site 114 volume estimated at step 508 is estimated based on the pressure decay observed during the instillation of the instillation fluid 105 into the wound site 114 at step 506, as previously described, Figure 5 The method 500 shown in the flowchart of FIG. 5 does not require additional steps and / or time than would otherwise be required to instill the instillation fluid 105 into the wound site 114. As step 510, the wound site 114 volume estimated at step 508 may optionally be stored for future use.
[0057] After estimating the wound site 114 volume at step 508, the NPWT system 100 may continue to be used at step 512 to provide NPWT therapy according to any number of different protocols. Figure 5 As shown in step 512 of method 500, according to various embodiments, NPWT therapy may continue one or more cycles of negative pressure application and fluid instillation using the NPWT system 100, wherein step 508 of estimating the volume of the wound site 114 is optionally repeated after some, all, or none of the additional steps 504 of applying negative pressure to the wound site 114 and / or step 506 of instilling the instillation fluid 105 into the wound site 114.
[0058] use Figure 5 The wound site 114 volume estimated by method 500 may be used for any number of different purposes. For example, as described above, according to some embodiments, the wound site 114 volume estimated during the instillation phase of NPWT treatment may be advantageously used to track the progress of wound site 114 healing. Figure 6 , shows a flow chart of a method 600 for monitoring wound site 114 healing by utilizing estimated wound site 114 volume measurements obtained at multiple time points during the course of NPWT treatment using NPWT system 100, according to an exemplary embodiment. Figure 6As shown, at step 602, the initial wound site 114 volume estimate is recorded at step 602 and can be used as a baseline to which subsequent wound site 114 volume estimates are compared to track the healing process. According to various embodiments, the estimate of the initial volume of the wound site 114 made at step 602 can be based on (or as) a reference Figure 5 Step 508 of method 500 is performed.
[0059] At step 604, after the initial wound site 114 volume is estimated at step 602, the volume of the wound site 114 is estimated and recorded at one or more additional times during treatment (e.g., once per day), wherein the time at which the volume of such one or more wound sites 114 is estimated and the determined volume values of the wound sites 114 are stored as data points within a memory of the treatment device 102 and / or presented to a user as an output of the treatment device 102 (e.g., via the communication interface 124 or the user interface 126). In some embodiments, the estimated wound volume may be plotted as a function of time.
[0060] At step 604, the additional wound site 114 volume estimated at one or more additional times during treatment may be estimated according to any number of different methods. For example, according to various embodiments, during subsequent occurrences of fluid instillation as part of continued NPWT treatment at step 512, at step 604, the estimated wound site 114 volume may be estimated according to (or as) Figure 5 The estimation of the volume of the wound site 114 is performed at step 508 of method 500. Alternatively or in addition, one or more of the additional wound site 114 volumes estimated at step 604 may be obtained according to any other method, such as based on a dynamic pressure response observed within the negative pressure circuit 200 of the NPWT system 100 during a purge event.
[0061] Since the additional wound site 114 volume estimates are obtained at step 604, at step 606, the estimated change in the wound site 114 volume over time may be used to determine the healing progress of the wound site 114. For example, step 606 may include comparing the wound site 114 volume estimate obtained at step 604 with one or more previous estimates of the wound site 114 volume (obtained at step 604 or step 602) to identify changes in the wound site 114 volume. In some embodiments, step 606 may further include determining the rate of wound site 114 healing based on the estimated change in the wound site 114 volume over time. In some embodiments, step 606 may include extrapolating or predicting the time when the wound site 114 will be completely healed based on a series of wound site 114 volume estimates stored by the controller 118. For example, step 606 may include predicting the time when the estimated wound site 114 volume will reach zero (or another threshold) based on the initial wound site 114 volume estimated at step 1002 and the series of additional wound site 114 volumes estimated at step 604.
[0062] According to some embodiments, in addition to using the wound site 114 volume estimate to monitor the wound site 114 healing progress (such as referenced above), Figure 6 In addition to or as an alternative to method 600 ), during instillation of the instillation fluid 105 into the wound site 115 , the wound site 114 volume estimate may be used to detect and / or prevent overfilling of the wound site 114 with the instillation fluid 105 .
[0063] See also Figure 7 The method 700 for preventing and / or detecting overfilling of a wound site 115 with an instillation fluid 105 during an instillation event begins at step 702 by obtaining an initial wound site 114 volume estimate. Figure 7 The instillation event corresponds to the reference Figure 5 In one embodiment of the method 500 of step 512 of continuing fluid instillation during NPWT treatment, the initial wound site 114 volume estimate obtained at step 702 may be equal to Figure 5 The wound site 114 volume is estimated at step 508 of method 500. Figure 7 Method 700 in Figure 7 In embodiments performed after a previous iteration of method 700, the wound site 114 volume estimate obtained at step 702 may correspond to the wound site 114 volume estimated at step 720 of the previous iteration of method 700. In still other embodiments, the wound site 114 volume estimate obtained at step 702 may be obtained according to any other number of other methods (such as in Figure 8The volume estimated at step 810 of method 800).
[0064] At step 704, the pneumatic pump 120 is operated to reach a predetermined negative pressure at any one or more of the tube 110, the removed fluid tank 106, the treatment device 102, the wound site 114, the pump 120, etc., after which the instillation fluid 105 is instilled into the wound site 114 at step 706. Figure 7 As shown, according to some embodiments, as the fluid is instilled into the wound site 114, at step 708, the pressure at any one or more of the tube 110, the removed fluid tank 106, the treatment device 102, the wound site 114, the pump 120, etc. can optionally be monitored in real time. In such embodiments, the measured real-time pressure can be compared to a model pressure decay curve (such as that described above with reference to FIG. Figure 5 The model pressure decay curve represents a volume corresponding to the estimated wound site 114 volume obtained at step 702 and the conditions under which the instillation fluid 105 is instilled into the wound site at step 706. Figure 7 As shown, in the event that the measured real-time pressure decay does not correspond to the expected pressure decay of the model pressure decay curve, the controller 118 may generate an alert to the user at step 710. In the event that the real-time pressure decay is changing at a rate greater than the expected rate, the controller 118 may also optionally stop the instillation of the instillation fluid 105 into the wound site 114 at step 712 to prevent overfilling of the fluid.
[0065] It should be understood that the measured real-time pressure decay may differ from the expected pressure decay predicted by the model data for any number of reasons. For example, in embodiments where the volume of the wound site 114 has decreased since the last time the volume of the wound site 114 was estimated, it is expected that the pressure decay observed due to the now smaller size of the wound site 114 will differ from the expected pressure decay predicted by the model data. Therefore, in some embodiments, the controller 118 may be configured to generate an alarm at step 710 and / or stop the instillation of the instillation fluid 105 at step 712 only if the difference between the measured pressure decay and the expected pressure decay exceeds a predetermined threshold. According to some embodiments, the threshold may correspond to a difference greater than about ±15%, and more specifically greater than about ±10%, and even more specifically greater than about ±5%.
[0066] If a difference between the real-time pressure measurement and the expected pressure measurement is not detected at step 708 (or if the difference does not exceed a predetermined threshold), then a determination is made at step 714 whether a predetermined target pressure has been reached at any one or more of the tube 110, the removed fluid canister 106, the treatment device 102, the wound site 114, the pump 120, etc. If it has been determined that the measured pressure is substantially equal to the predetermined target pressure, then the instillation of the instillation fluid 1045 is stopped at step 716. According to various embodiments, the predetermined target pressure at step 714 may be between about -15 mmHg and about 15 mmHg, more specifically between about -5 mmHg and 5 mmHg, and even more specifically about 0 mmHg.
[0067] According to some embodiments, if the target pressure has not been reached at step 714, step 706 of instilling fluid into the wound site 114 (and optionally step 708 of comparing the monitored pressure to the expected pressure based on model data) may be repeated until it is determined at step 714 that the target pressure has been reached.
[0068] However, if Figure 7 As shown, according to some embodiments, method 700 may optionally include step 718, which may provide an additional layer of overfill prevention for the NPWT system 100 in the event that the comparison of the measured wound site 114 pressure with the target pressure is insufficient to detect a potential overfill condition. In such embodiments, at step 718, the total volume of the instillation fluid 105 instilled into the wound site 114 since the start of step 706 may be compared to the wound site 114 volume estimate obtained at step 702, wherein if the volume of the instillation fluid is determined to be substantially the same as the estimated wound site 114 volume, then the instillation of the instillation fluid 105 is stopped at step 716. It should be understood that by preventing the volume of the instilled amount of the instillation fluid 105 from exceeding the estimated volume of the wound site 114, Figure 7 Step 718 of method 700 provides an additional level of protection against overfilling for the NPWT system 100. Alternatively, if the volume of instilled instillation fluid 105 is less than the estimated wound site 114 volume, the method 700 may continue to instill fluid into the wound site 114 at step 706.
[0069] According to some embodiments, at step 720, a current volume of the wound site 114 may optionally be estimated based on the most recent instillation of fluid during step 706, wherein the most recent estimated wound site 114 volume is stored at step 722 for any number of future uses (e.g., for use in accordance with Figure 7 The method 700 of future instillation of a fluid according to Figure 6In the case where the fluid instillation is stopped at step 716 in response to determining at step 714 that the target pressure has been reached, the target pressure may be measured with reference to the reference pressure. Figure 5 The wound site 114 volume is estimated in a manner similar to that described in step 508 of method 500, wherein the pressure decay observed during fluid instillation at any one or more of the tube 110, the removed fluid canister 106, the treatment device 102, the wound site 114, the pump 120, etc. is compared to the model pressure decay data to identify the corresponding volume of the wound site 114. If instillation of the instillation fluid 105 is stopped at step 716 in response to determining at step 718 that the volume of the instilled fluid is substantially equal to or greater than the estimated wound site 114 volume, then according to some embodiments, the estimated wound site 114 volume at step 720 may correspond to a previous wound site 114 volume estimate.
[0070] As described above, according to some embodiments, it may be desirable to validate the wound site 114 volume estimated during instillation of fluid into the wound site 114 (such as with reference to FIG. 1 ) relative to wound site 114 volume estimates obtained according to any other number of different methods. Figure 5 Method 500 and / or Figure 7 700). Figure 8 , shows an exemplary embodiment of one such method 800 for verifying a wound site 114 volume estimate obtained during fluid instillation against a wound site 114 volume estimated according to another method, or vice versa. More specifically, in Figure 8 In the method 800 shown in the flowchart of FIG. Figure 4 The described embodiment compares a wound site 114 volume estimate based on a dynamic pressure response observed during purging of various portions of the negative pressure circuit 200 of the NPWT system 100 with a wound site 114 volume estimate based on fluid instillation to provide an NPWT system 100 with a higher confidence wound site 114 volume estimate.
[0071] like Figure 8As shown, according to one embodiment of the method 800, at step 802, the pneumatic pump 120 is operated to achieve a desired negative pressure within the negative pressure circuit 200. It should be understood that in embodiments in which the tube valve 111' is in a closed configuration, step 802 may additionally include a step of opening the tube valve 111'. Once the desired negative pressure has been achieved in the negative pressure circuit 200, the negative pressure circuit 200 is purged by allowing air from the surrounding environment to flow into the negative pressure circuit 200 (e.g., via the graduated leak system 113) until a predetermined threshold pressure is reached within the negative pressure circuit 200. While the negative pressure circuit 200 is purged during step 804, the pressure decay within the negative pressure circuit 200 is monitored (using, for example, the pressure sensor 115).
[0072] Once the predetermined threshold pressure has been reached within the negative pressure circuit 200, the pneumatic pump 120 is again operated at step 806 to exhaust air from the negative pressure circuit 200, thereby achieving a desired negative pressure with the negative pressure circuit 200. Once the desired negative pressure has been achieved, the tube valve 111' is closed at step 808, thereby fluidly isolating the removed fluid tank circuit from the wound site circuit.
[0073] At step 810, the removed fluid tank circuit is purged by allowing air from the ambient environment to flow into the removed fluid tank circuit (e.g., via the graduated leak system 113) until a predetermined threshold pressure is reached within the removed fluid tank circuit. While the removed fluid tank circuit is purged during step 810, a pressure decay within the removed fluid tank circuit is monitored (using, for example, the pressure sensor 115). At step 812, a first volume of the wound site 114 is estimated using the pressure decays observed within the negative pressure circuit 200 and the removed fluid tank circuit during steps 804 and 810, respectively. More specifically, the volume of the wound site 114 is calculated by comparing the observed pressure decays from steps 804 and 810 with model pressure decay data to identify corresponding volumes representing the volumes of the negative pressure circuit 200 and the removed fluid tank circuit, from which the wound site 114 can then be estimated. As described with reference to FIG. Figure 8 As described in steps 802-812 of method 800, non-limiting examples of additional methods and / or system embodiments for calculating the volume of the wound site 114 using the pressure decay observed during some or all of the purging in the negative pressure circuit 200 are outlined in related co-pending U.S. provisional application 62 / 714,229, entitled “WOUND THERAPY SYSTEM WITH WOUND VOLUME ESTIMATION,” filed on August 3, 2018, the entire disclosure of which is incorporated herein by reference.
[0074] At step 814, the instillation fluid 105 is instilled into the wound site 114 until the wound site 114 is at a level consistent with the reference Figure 5 In a manner similar to that discussed above with respect to step 506 of method 500 of FIG. 5 , a predetermined pressure is reached at any one or more of the tube 110, the removed fluid tank 106, the treatment device 102, the wound site 114, the pump 120, etc. At step 816, based on the pressure decay observed at any one or more of the tube 110, the removed fluid tank 106, the treatment device 102, the wound site 114, the pump 120, etc. during the instillation of the fluid into the wound site 114 at step 814, and at a rate comparable to that of the reference pressure. Figure 5 The volume of the second wound site 114 may be estimated in a similar manner as described in step 508 of method 500. It should be appreciated that steps 814 and 816 may optionally be performed before steps 810 and 812, or alternatively simultaneously with steps 810 and 812, according to some embodiments.
[0075] At step 818, the first wound site 114 volume estimated at step 812 is compared to the second wound site 114 volume estimated at step 816. If it is determined at step 818 that the first volume and the second volume are not substantially similar to each other, an alarm may be generated at step 820. If it is determined at step 818 that the first volume and the second volume are substantially similar to each other, one, both, or an average of the volume estimate of the first wound site 114 and the volume estimate of the second wound site 114 are stored at step 822. It should be understood that at step 818, any degree of similarity may be used to determine whether the first volume and the second volume are substantially similar to each other. According to some embodiments, the first volume and the second volume may be determined at step 818 to be substantially similar to each other if they differ from each other by no more than approximately 15%, more specifically, by no more than approximately 10%, and even more specifically, by no more than approximately 5%.
[0076] It should be understood that Figure 8 The method 800 may be performed any number of times and at any time during the NPWT treatment provided using the NPWT system 100. For example, according to some embodiments, the method 800 is performed after initial use of the NPWT system 100, after which the NPWT system 100 may be operated according to the methods disclosed herein, or any of any other number of different NPWT treatments, or other treatment regimens. Figure 8 The method 800 is followed by Figure 7In an embodiment of method 700 of the present invention, the wound site 114 volume estimate obtained at step 702 during an initial iteration of method 700 may correspond to the wound site 114 volume estimate stored at step 820 of method 800. In a subsequent iteration of method 700, the wound site 114 volume estimate obtained at step 702 may correspond to the wound site 114 volume stored at step 722 during an immediately previous iteration of method 700.
[0077] In other embodiments, Figure 8 Some or all of method 800 may be repeated any desired number of times. For example, in some embodiments, with each iteration of method 800, a cross-check between the estimated wound site 114 volume based on the purge events of steps 804 and 810 and the estimated wound site 114 volume based on the fluid instillation of step 814 may be desired, in which case the cross-check may be fully repeated with each iteration. Figure 8 In other embodiments, it may be desirable to alternate the estimation of the wound site 114 volume based on the purge events of steps 804 and 810 with the estimation of the wound site 114 volume based on the fluid instillation at step 814. In addition, according to various embodiments (including the above-discussed Figure 8 those embodiments of Figure 8 Some or all iterations of method 800 of FIG. 700 may optionally incorporate some or all of steps 708, 710, 712, 714, 716, 718, and 720 of method 700 of FIG. 700 between steps 815 and 816. According to various embodiments, Figure 6 The method 600 of monitoring healing of a wound site 114 may also be incorporated into any of the methods disclosed herein.
[0078] Generally, the volume of the wound site 114 is defined by the entire interior that extends between the wound site 114 and the drape layer 117 attached to the skin 116 around the wound site 114. At various points during treatment using the NPWT system 100, located within and defining the volume of the wound site may be any one and any combination of the wound dressing 112, the fluid 121, and / or the dead space 119. It should be understood that unless the wound dressing 112 is replaced during treatment, the volume of the wound site 114 occupied by the wound dressing 112 will generally remain constant during treatment, while the portion of the volume of the wound site 114 occupied by the fluid 121 and / or the dead space 119 may change over time.
[0079] It should be appreciated that according to various embodiments, the controller 118 may be programmed to allow the NPWT system 100 to determine a volume relative to the wound site 114 by any or all of the methods described herein.
[0080] Configuration of the exemplary embodiment
[0081] The construction and arrangement of the system and method shown in various exemplary embodiments are only exemplary. Although only several embodiments are described in detail in the present disclosure, many modifications are possible (for example, the size, size, structure, shape and ratio changes, parameter values, installation arrangements, use of materials, colors, orientations, etc. of various elements). For example, the position of the element can be reversed or otherwise changed, and the property or quantity or position of the discrete element can be changed or changed. Therefore, all such modifications are intended to be included in the scope of the present disclosure. The order or sequence of any process or method step can be changed or reordered according to an alternative embodiment. Without departing from the scope of the present disclosure, other replacements, modifications, changes and omissions can be made to the design, operating conditions and arrangement of the exemplary embodiments.
[0082] The present disclosure contemplates methods, systems and program products on any machine-readable medium for implementing various operations. The embodiments of the present disclosure can be implemented using existing computer processors, or by a dedicated computer processor of an appropriate system merged for this purpose or another purpose, or by a hard-wired system. The embodiments within the scope of the present disclosure include program products, which include machine-readable media for carrying or having machine-executable instructions or data structures stored thereon. Such machine-readable media can be any available medium that can be accessed by a general or special-purpose computer or other machine with a processor. By way of example, such machine-readable media may include RAM, ROM, EPROM, EEPROM, CD-ROM or other optical disk storage devices, magnetic disk storage devices or other magnetic storage devices, or any other medium that can be used to carry or store desired program codes in the form of machine-executable instructions or data structures and can be accessed by a general or special-purpose computer or other machine with a processor. The above combination is also included in the scope of machine-readable media. Machine-executable instructions include instructions and data that, for example, enable a general-purpose computer, a special-purpose computer or a special-purpose processing machine to perform a specific function or function group.
[0083] Although the accompanying drawings show a specific order of method steps, the order of steps may be different from the order depicted. Moreover, two or more steps may be performed simultaneously or partially simultaneously. Such variations will depend on the selected software and hardware systems and the designer's choice. All such variations are within the scope of the present disclosure. Similarly, software implementations can be implemented by standard programming techniques with rule-based logic and other logic to implement various connection steps, processing steps, comparison steps, and decision steps.
Claims
1. A wound treatment system, comprising: Pumps; a wound dressing configured to be applied to a wound site; a fluid tube fluidly connecting the pump to the wound dressing; and A controller, the controller being configured to: monitoring pressure during instillation of fluid into the wound site; and determining a volume of the fluid instilled into the wound site by comparing pressure measurements obtained from pressure monitored during instillation of the fluid into the wound site with model pressure decay data, The model pressure decay data includes changes in pressure over time when the instillation fluid is instilled into wound sites of different volumes under a variety of clinically relevant conditions and states.
2. A wound treatment system according to claim 1, wherein the controller is configured to store the determined volume of the fluid instilled into the wound site.
3. A wound treatment system according to claim 1, wherein the controller is configured to determine the volume of fluid dripped into the wound site during each of one or more drip events occurring during treatment of the wound site.
4. A wound treatment system according to claim 3, wherein the controller is configured to store each of the determined volumes.
5. A wound treatment system according to claim 4, wherein the controller is configured to monitor healing of the wound site based on the stored determined volume.
6. The wound treatment system of claim 1, further comprising a source of instillation fluid, the controller being further configured to operate the pump to instill the fluid into the wound site.
7. A wound treatment system according to claim 6, wherein the controller is configured to stop dripping the fluid into the wound site when a first predetermined pressure is detected.
8. A wound treatment system according to claim 6, wherein the controller is configured to stop operation of the pump when a pressure of substantially 0 mmHg is detected.
9. The wound treatment system of claim 1, wherein the controller is further configured to operate the pump to exhaust air from the wound site.
10. The wound treatment system of claim 6, wherein the controller is further configured to operate the pump to exhaust air from the wound site.
11. The wound treatment system of claim 1 , further comprising a source of instillation fluid.
12. The wound treatment system of claim 11, wherein the controller is further configured to: operating the pump to exhaust air from the wound site to achieve a predetermined negative pressure; When the pressure equal to the predetermined negative pressure is detected, operating the pump to drip the fluid into the wound site; as well as When it is detected that the measured pressure is equal to the predetermined target pressure, the instillation of the fluid into the wound site is stopped.
